Home
Ractigen Therapeutics

Ractigen Therapeutics Market Share Analysis for May 2026

Final results from an Investigator-Initiated Trial presented for the first time, demonstrating favorable safety, significant target engagement, and encouraging clinical & biomarker signals Abstract honored with prestigious "Abstracts of Distinction" award by AAN Science Committee, recognizing top quality and interest Phase I clinical trial for RAG-17 advancing as planned with dosing successfully completed for the

Industry: N/A

Domainractigen.com

Year Founded2016

Employees51 - 200

Annual Revenue$2M - $5M

Ractigen Therapeutics

Ractigen Therapeutics (including company regionals)

ractigen.com

See more website traffic and engagement information

Ractigen Therapeutics Revenue up to May 2026 is 2M - 5M

revenue generated by Ractigen Therapeutics top domains

Ractigen Therapeutics top domains revenue over 3 years

Revenue for Ractigen Therapeutics top domains

ractigen.com2M - 5M

See more with Sales Intelligence

Total visits to Ractigen Therapeutics's top domains

Understand Ractigen Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ractigen.com3K

See more with Sales Intelligence

Avg. visit duration in Ractigen Therapeutics's top domains

Analyze Ractigen Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ractigen.com00:00:40

See more with Sales Intelligence

Avg. pageviews on Ractigen Therapeutics's top domains

See how Ractigen Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ractigen.com1.70

See more with Sales Intelligence

Ractigen Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Ractigen Therapeutics

These are the website technologies, by industry, used by Ractigen Therapeutics top domains

Widget (5)

Twemoji

Content Management System (4)

WordPress

Audio Video Media (2)

Vimeo

Mobile (2)

Meta Viewport

More Technologies

3

See all

News & Signals from Ractigen Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRactigen Therapeutics, Inc. attended event American Diabetes Association (ADA) 86th Scientific Sessions on Jun 5th '26.New Orleans, USA, June 6, 2026 - Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced that a late-breaking abstract on LiCO-saUcp1, its first-in-class saRNA candidate for obesity, has been accepted for poster presentation at the American Diabetes Association (ADA) 86th Scientific Sessions, being held June 5-8, 2026, in New Orleans, Louisiana.

NewsRactigen Therapeutics, Inc. attends event 2026 AAN Annual Meeting.Ractigen Therapeutics presents positive Phase I data for RAG-17 in SOD1-ALS at the 2026 AAN Annual Meeting, demonstrating 81% reduction in neurofilament light chain.

NewsRactigen Therapeutics, Inc. attends event EAU 2025.Ractigen's RAG-01 shows promising early complete responses in Phase I NMIBC trial, data Presented at EAU 2025.